These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 19890262)

  • 1. Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine.
    Hong LE; Summerfelt A; Buchanan RW; O'Donnell P; Thaker GK; Weiler MA; Lahti AC
    Neuropsychopharmacology; 2010 Feb; 35(3):632-40. PubMed ID: 19890262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia.
    Ehrlichman RS; Gandal MJ; Maxwell CR; Lazarewicz MT; Finkel LH; Contreras D; Turetsky BI; Siegel SJ
    Neuroscience; 2009 Jan; 158(2):705-12. PubMed ID: 19015010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine Alters Lateral Prefrontal Oscillations in a Rule-Based Working Memory Task.
    Ma L; Skoblenick K; Johnston K; Everling S
    J Neurosci; 2018 Mar; 38(10):2482-2494. PubMed ID: 29437929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of subanesthetic doses of ketamine on sensorimotor information processing in healthy subjects.
    Micallef J; Guillermain Y; Tardieu S; Hasbroucq T; Possamaï C; Jouve E; Blin O
    Clin Neuropharmacol; 2002; 25(2):101-6. PubMed ID: 11981237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced auditory evoked gamma-band response and schizophrenia-like clinical symptoms under subanesthetic ketamine.
    Curic S; Leicht G; Thiebes S; Andreou C; Polomac N; Eichler IC; Eichler L; Zöllner C; Gallinat J; Steinmann S; Mulert C
    Neuropsychopharmacology; 2019 Jun; 44(7):1239-1246. PubMed ID: 30758327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
    Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
    Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycine attenuates impairments of stimulus-evoked gamma oscillations in the ketamine model of schizophrenia.
    Haaf M; Curic S; Steinmann S; Rauh J; Leicht G; Mulert C
    Neuroimage; 2022 May; 251():119004. PubMed ID: 35176492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans.
    Muthukumaraswamy SD; Shaw AD; Jackson LE; Hall J; Moran R; Saxena N
    J Neurosci; 2015 Aug; 35(33):11694-706. PubMed ID: 26290246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute ketamine dysregulates task-related gamma-band oscillations in thalamo-cortical circuits in schizophrenia.
    Grent-'t-Jong T; Rivolta D; Gross J; Gajwani R; Lawrie SM; Schwannauer M; Heidegger T; Wibral M; Singer W; Sauer A; Scheller B; Uhlhaas PJ
    Brain; 2018 Aug; 141(8):2511-2526. PubMed ID: 30020423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine Dysregulates the Amplitude and Connectivity of High-Frequency Oscillations in Cortical-Subcortical Networks in Humans: Evidence From Resting-State Magnetoencephalography-Recordings.
    Rivolta D; Heidegger T; Scheller B; Sauer A; Schaum M; Birkner K; Singer W; Wibral M; Uhlhaas PJ
    Schizophr Bull; 2015 Sep; 41(5):1105-14. PubMed ID: 25987642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine alters oscillatory coupling in the hippocampus.
    Caixeta FV; Cornélio AM; Scheffer-Teixeira R; Ribeiro S; Tort AB
    Sci Rep; 2013; 3():2348. PubMed ID: 23907109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine modulates theta and gamma oscillations.
    Lazarewicz MT; Ehrlichman RS; Maxwell CR; Gandal MJ; Finkel LH; Siegel SJ
    J Cogn Neurosci; 2010 Jul; 22(7):1452-64. PubMed ID: 19583475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive analysis of auditory event-related potentials and network oscillations in an NMDA receptor antagonist mouse model using a novel wireless recording technology.
    Schuelert N; Dorner-Ciossek C; Brendel M; Rosenbrock H
    Physiol Rep; 2018 Aug; 6(16):e13782. PubMed ID: 30155997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia.
    Hajós M; Hoffmann WE; Kocsis B
    Biol Psychiatry; 2008 Jun; 63(11):1075-83. PubMed ID: 18261715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder.
    McMillan R; Sumner R; Forsyth A; Campbell D; Malpas G; Maxwell E; Deng C; Hay J; Ponton R; Sundram F; Muthukumaraswamy S
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109838. PubMed ID: 31843628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excitation of Putative Glutamatergic Neurons in the Rat Parabrachial Nucleus Region Reduces Delta Power during Dexmedetomidine but not Ketamine Anesthesia.
    Melonakos ED; Siegmann MJ; Rey C; O'Brien C; Nikolaeva KK; Solt K; Nehs CJ
    Anesthesiology; 2021 Oct; 135(4):633-648. PubMed ID: 34270686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ketamine on precipitated opiate withdrawal.
    Jovaisa T; Laurinenas G; Vosylius S; Sipylaite J; Badaras R; Ivaskevicius J
    Medicina (Kaunas); 2006; 42(8):625-34. PubMed ID: 16963828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypericum extract reverses S-ketamine-induced changes in auditory evoked potentials in humans - possible implications for the treatment of schizophrenia.
    Murck H; Spitznagel H; Ploch M; Seibel K; Schaffler K
    Biol Psychiatry; 2006 Mar; 59(5):440-5. PubMed ID: 16165104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta Vs Gamma Auditory Steady State Synchrony in Schizophrenia.
    Puvvada KC; Summerfelt A; Du X; Krishna N; Kochunov P; Rowland LM; Simon JZ; Hong LE
    Schizophr Bull; 2018 Feb; 44(2):378-387. PubMed ID: 29036430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans.
    de la Salle S; Shah D; Choueiry J; Bowers H; McIntosh J; Ilivitsky V; Knott V
    Front Pharmacol; 2019; 10():455. PubMed ID: 31139075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.